$MMSI

Merit Medical Systems (MMSI) announced Sheri Lewis as EVP of Global Operations, replacing Mr. Peterson. Shares are at $90.68, up 6.67% in 30 days and 49.51% in 90 days. Analysts suggest a fair value of $100.27, implying a 9.6% undervaluation, but note a high P/E of 37.2x. The company's focus on operational efficiency and product expansion drives margin growth, though risks include reimbursement delays and trade issues.

Peterson Neil W. (CHIEF OPERATING OFFICER) sold 7,500 shares of MERIT MEDICAL SYSTEMS INC (MMSI) at $90.45 ($0.68M total) on 2026-08-24.

Merit Medical (MMSI) HR chief Michel J. Voigt gifted 650 shares of common stock as a charitable donation on 2026-08-24. Post-transaction, Voigt holds 45,412 direct shares and 2,265 indirect shares via a 401(k) plan. Voigt also holds non-qualified stock options on 17,542 shares with varying exercise prices and expiration dates.

Wolfpack Research reported Flotek Industries (FTK) lost a $400M contract, potentially halving its backlog. Fugazi Research criticized Aeva Technologies (AEVA) as a struggling startup. Bristlemoon Research argued Macy's (M) is overvalued. L3Harris (LHX) CEO departed over conduct violations. Ameresco (AMRC) CFO and GC resigned. Viking Therapeutics (VKTX) COO and Merit Medical (MMSI) COO departed. Boston Beer (SAM) CFO is stepping down. Edwin Dorsey predicts long-term trouble for DraftKings (DKNG)

MERIT MEDICAL SYSTEMS INC (MMSI) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 ​ ​ ​ ​ ​ ​ Merit Medical Announces Global Operations Leadership Transition SOUTH JORDAN, Utah, August 19, 2026 (GLOBE NEWSWIRE) – Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer of healthcare technology, today announced that Sheri Lewis has

Merit Medical Systems (MMSI) reported Q2 2026 sales of $418.84 million and net income of $38.8 million, and raised its full-year 2026 revenue outlook to $1.63 billion to $1.64 billion, according to the company. The article notes ongoing product recalls and reimbursement risks and mentions a 2029 narrative of about $1.8 billion revenue and $213.7 million earnings.

Merit Medical Systems (MMSI) reported Q2 2026 revenue of $418.8 million, up 10% GAAP, and non-GAAP EPS of $1.19. Non-GAAP operating margin was 22.6% and free cash flow $51.9 million. The company raised 2026 revenue guidance to $1.631B-$1.643B and non-GAAP EPS to $4.25-$4.35, and guided Q3 revenue to $408M-$413M.

Peterson Neil W. (CHIEF OPERATING OFFICER) sold 21,449 shares of MERIT MEDICAL SYSTEMS INC (MMSI) at $85.00 ($1.82M total) on 2026-08-04.

Merit Medical Systems reported Q2 revenue of $418.8M, above analysts’ $405.3M estimate, and adjusted EPS of $1.19 versus $0.96. The company slightly raised full-year revenue guidance to $1.64B and adjusted EPS to $4.30 at the midpoint. Management cited Biolife and C2 integration, oncology launches (OneMark, SCOUT MD), and margin gains.

Merit Medical Systems Inc (NASDAQ:MMSI) posted better-than-expected earnings for the second quarter on Thursday. The company posted adjusted EPS of $1.19, beating market estimates of 96 cents per share. The company’s sales came in at $418.843 million versus expectations of $405.268 million. Merit Medical Systems raised its FY2026 adjusted EPS guidance from $4.01-$4.15 to $4.25-$4.35 and increased its sales forecast from $1.612 billion-$1.634 billion to $1.631 billion-$1.643 billion.